Disclosure Panels Details Page
Cervical/Uterine Cancers Panel - Disclosures as of 04/24/2024
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Nadeem Abu-Rustum MD | GRAIL | NCCN | None | None | 03/12/2024 |
| Rebecca Arend MD | Champions Oncology, Inc. Exelixis Inc. GSK ImmunoGen, Inc. Merck & Co., Inc. VBL Therapeutics |
GSK Kiyatec Merck & Co., Inc. Seagen Inc. SUTRO Biopharma, Inc. VBL Therapeutics |
None | None | 11/17/2023 |
| Emma Barber MD | Eli Lilly and Company | Merck & Co., Inc. | None | None | 10/30/2023 |
| Marian Birkeland PhD | None | None | None | None | 04/02/2024 |
| Nicole Blankenhorn | None | None | None | None | 03/04/2024 |
| Kristin Bradley MD | None | None | None | American Brachytherapy Society|UpToDate, contributing author | 04/07/2024 |
| Rebecca Brooks MD | None | None | AstraZeneca Pharmaceuticals LP Curio Science Haymarket Media MedLogix OncLIve |
Steering Committee for IQVIA NRG GY 3035 clinical trial | 12/09/2023 |
| Susana Campos MS,MPH,MD | None | AstraZeneca Pharmaceuticals LP Eisai Inc. GSK Merck & Co., Inc. |
None | None | 11/11/2023 |
| Junzo Chino MD | KM Pharmaceutical Consulting LLC | Merck & Co., Inc. | Stryker | None | 02/12/2024 |
| Hye Sook Chon MD | None | Clinical Care Options Eisai Inc. |
None | None | 02/23/2024 |
| Marta Ann Crispens MD | None | None | None | None | 04/05/2024 |
| Shari Damast MD | MyCareGorithm | None | None | None | 12/14/2023 |
| Sara Espinosa PhD | None | None | None | None | 04/01/2024 |
| Christine Fisher MPH,MD | Vail Health Shaw Cancer Center | None | None | None | 01/23/2024 |
| Peter Frederick MD | None | None | None | None | 01/03/2024 |
| David Gaffney PhD,MD | Elekta | Merck & Co., Inc. | None | Co-Chair, Gyn Committee, NRG Oncology | 01/14/2024 |
| Stephanie Gaillard PhD,MD | AstraZeneca Pharmaceuticals LP Blueprint Medicines Clovis Oncology Compugen GSK ImmunoGen, Inc. SignPath Pharma Tempest Volastra |
Organon Verastem |
None | None | 04/17/2024 |
| Robert Giuntoli II MD | AstraZeneca Pharmaceuticals LP | Buckingham, Doolittle & Burroughs, LLC Eckert Seamans Cherin & Mellott, LLC Kolsby, Gordon, Robin & Shore PC Rawle & Henderson, LLP Roetzel & Andress |
None | None | 01/10/2024 |
| Scott Glaser MD | Aiden Industries | None | None | None | 03/25/2024 |
| Kristina Gregory MSN,RN | None | None | None | None | 01/10/2024 |
| Evelyn Handel PharmD,BCPS,BCOP | None | None | None | None | 02/02/2024 |
| Erin Hesler | None | None | None | None | 12/22/2023 |
| Brooke Howitt MD | None | Cartography Biosciences Santa Ana Bio Tempus |
None | None | 02/16/2024 |
| Kari Kendra PhD,MD | Bristol Myers Squibb checkmate pharmaceuticals GSK Immunocore medspace Melanoma Research Foundation Merck & Co., Inc. National Institute on Aging Regeneron Pharmaceuticals, Inc. Varian Medical Systems |
None | None | None | 11/03/2023 |
| Lisa Landrum MD,PhD | None | GSK | None | None | 02/03/2024 |
| Jayanthi Lea MD | None | AstraZeneca Pharmaceuticals LP | None | None | 03/29/2024 |
| Nita Lee MD,MPH | None | Cancer Support Community National Ovarian Cancer Coalition |
None | None | 10/06/2023 |
| Gina Mantia-Smaldone MD | None | None | None | None | 04/21/2024 |
| Andrea Mariani MD | None | None | None | None | 12/17/2023 |
| Nicole McMillian MS | None | None | None | None | 04/22/2024 |
| David Mutch MD | None | None | None | None | 02/10/2024 |
| Christa Nagel MD | None | None | None | None | 04/01/2024 |
| Larissa Nekhlyudov MD,MPH | None | None | None | None | 12/13/2023 |
| Karina Nieto MD | None | None | None | None | 01/16/2024 |
| Sharon Park PharmD,BCOP | None | None | None | None | 02/09/2024 |
| Mirna Podoll MD | None | None | None | None | 06/28/2023 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 03/13/2024 |
| Kerry Rodabaugh MD | None | None | None | None | 01/06/2024 |
| Ritu Salani MBA,MD | Genentech, Inc. Merck & Co., Inc. Nykode Therapeutics |
Eisai Inc. GSK ImmunoGen, Inc. Merck & Co., Inc. Regeneron Pharmactcls SeaGen |
None | Elsevier|UpToDate | 01/11/2024 |
| Vaishnavi Sambandam PhD | None | None | None | None | 02/06/2024 |
| John Schorge MD | None | None | None | None | 02/12/2024 |
| Scott Schuetze PhD,MD | Adaptimmune Advenchen Ayala Pharmaceuticals BioAtla Boehringer Ingelheim GmbH Cogent Biosciences, Inc Epizyme GSK Inhibrx, Inc Pfizer Inc. PTC Therapeutics, Inc RAIN Therapeutics Shanghai Pharmaceuticals TRACON Pharmaceuticals, Inc. |
None | None | UpToDate | 12/27/2023 |
| Jean Siedel MS,DO | None | None | None | None | 01/23/2024 |
| Rachel Sisodia MD | None | None | None | None | 05/30/2023 |
| Pamela Soliman MPH,MD | GSK Leap Therapeutics Merck & Co., Inc. Novartis Pharmaceuticals Corporation |
Expert Perspectives® in Endometrial Cancer GSK Medscape |
None | None | 04/11/2024 |
| Stefanie Ueda MD | None | None | None | None | 02/13/2024 |
| Renata Urban MD | None | None | Clinical Care Options, Inc. | Royalties received as author, UpToDate, Inc. | 11/14/2023 |
| Erin Vidic | None | None | None | None | 12/15/2023 |
| Amanda Visnick OCN,RN,BSN | None | None | None | None | 04/12/2024 |
| Emily Wyse | None | None | None | None | 02/10/2024 |